Sustainability | March 06, 2022
Aurobindo Pharma Foundation dedicates mini-lift irrigation scheme
With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle
With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle
According to an Injury Surveillance Report by NCA last year, 14.75 % of players sustained shoulder injuries, 13.11% of players sustained knee injuries and almost 74 % players suffer from career-threatening Anterior Cruciate Ligament (ACL) injuries in the 1st two years of return to sport
Dr. Muffazal Lakdawala performs the largest series of complete robotic gastric bypass surgery in India
The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer
Around 85% of ALS patients suffer from a progressive loss of bulbar functionality
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
The company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug
It plans launch various other health monitoring tools for smartphones, making existing devices obsolete
Covaxin is not approved in the USA for any age group
Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
